FDA Approved Medical Products for:

Dopamine beta hydroxylase deficiency

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name droxidopa
Trade Name
(Manufacturer Name)
Northera
(Chelsea Therapeutics, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy.
More Information about this product Drug Information Portal